HPV-associated SCC of the Oropharynx click to access explanations in the original CAP template

** Please also refer to H&N biomarker protocol (HeadNeckBiomarkers 2.3.0.0, Apr-2026) for possible ancillary testings.

** If HPV is negative, please consider using the HPV-independent oropharynx and hypopharynx cancers protocol.

** Please also refer to additional specimens and frozen sections for margin status.

** Please include also intraparotid and periparotid lymph nodes, in addition to the lymph nodes of the neck dissections.

pT1: Tumor is less than or equal to 2 cm in greatest dimension
pT2: Tumor greater than 2 cm but less than or equal to 4 cm in greatest dimension
pT3: Tumor is greater than 4 cm in greatest dimension or extension to lingual surface of epiglottis
pT4: Tumor invades any of the following: larynx; OR deep / extrinsic muscle of the tongue (genioglossus, hypoglossus, palatoglossus, and styloglossus); OR pterygoid muscles (medial and / or lateral); OR hard palate; OR mandible; OR pterygoid plates (medial and / or lateral); OR nasopharynx; OR skull base; OR encases carotid artery.